GURU.Markets stock price, segment price, and overall market index valuation
The company's share price EDAP TMS S.A.
EDAP TMS is a company developing minimally invasive devices for the treatment of urological diseases. Its stock price reflects the pace of clinical adoption of its technologies, particularly high-intensity focused ultrasound (HIFU).
Share prices of companies in the market segment - Therapeutic medical equipment
EDAP TMS is a global leader in therapeutic ultrasound, offering minimally invasive devices for the treatment of prostate cancer and kidney stones. We classify it as "Therapeutic Medical Equipment." The graph below illustrates the growth of this innovative medical sector.
Broad Market Index - GURU.Markets
EDAP TMS is a French medical company and a global leader in therapeutic ultrasound for urology. As an innovator, it is included in our GURU.Markets index. The chart below shows the overall market trend. Compare it with EDAP's performance to assess the state of the sector.
Change in the price of a company, segment, and market as a whole per day
EDAP - Daily change in the company's share price EDAP TMS S.A.
Daily fluctuations in the shares of EDAP TMS S.A., a manufacturer of medical equipment for urology, reflect the volatility of the MedTech sector. This indicator, a measure of sensitivity to equipment sales and regulatory approvals, serves as a basis for analysis.
Daily change in the price of a set of shares in a market segment - Therapeutic medical equipment
Daily fluctuations in the shares of EDAP TMS S.A., a manufacturer of medical equipment for urology, reflect the volatility of the MedTech sector. This indicator, a measure of sensitivity to equipment sales and regulatory approvals, serves as a basis for analysis.
Daily change in the price of a broad market stock, index - GURU.Markets
EDAP TMS is a French company, a pioneer in non-invasive ultrasound treatment. This medical technology company's shares are driven by news of its technology being implemented in clinics around the world. Its unique story is part of the overall volatility of the innovative healthcare sector.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization EDAP TMS S.A.
EDAP TMS S.A.'s year-over-year performance is a story of its noninvasive technologies being introduced into urology. Its market capitalization growth over the past 12 months reflects increased sales of its high-intensity focused ultrasound (HIFU) systems for prostate cancer treatment, an increasingly popular alternative to surgery and radiation therapy.
Annual dynamics of market capitalization of the market segment - Therapeutic medical equipment
EDAP TMS S.A. is a French medical company, a leader in non-invasive ultrasound treatment. This chart shows how its unique technology, growing hospital adoption, and competition from traditional surgical methods are driving its rapid growth.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
EDAP, with its non-invasive treatment technology, is a growth story in medicine. Its stock price is determined not by the economy, but by the speed of adoption by doctors and the insurance system. The chart reflects the potential of this breakthrough technology in the vast urology market, regardless of the economic climate.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization EDAP TMS S.A.
EDAP TMS produces medical equipment for minimally invasive treatment of urological conditions. Its monthly growth reflects sales of its Focal One and Sonolith systems. The growing number of installations in hospitals worldwide and quarterly revenue reports are the main drivers of its value.
Monthly dynamics of market capitalization of the market segment - Therapeutic medical equipment
EDAP TMS S.A. is a French company and a global leader in therapeutic ultrasound. The dynamics of its sector, shown in the graph, reflect innovation in medicine. Against this backdrop, one can appreciate how its minimally invasive technologies for the treatment of prostate cancer and kidney stones are gaining recognition in the global medical equipment market.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
EDAP TMS produces medical equipment for urology. The company's success depends on sales of its systems to hospitals worldwide. The chart shows how much of the stock's performance is tied to revenue reports and news of marketing approvals in new countries, rather than to general stock market movements.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization EDAP TMS S.A.
EDAP TMS, a manufacturer of medical equipment for minimally invasive treatment of urological diseases, whose weekly stock price reflects demand for new medical technologies. Equipment sales data and regulatory approvals shape short-term trends.
Weekly dynamics of market capitalization of the market segment - Therapeutic medical equipment
EDAP TMS is a leader in non-invasive ultrasound treatment. The chart compares the company's weekly performance with the medical equipment sector. This helps us understand whether its stock price fluctuations are driven by the introduction of its unique technologies or by general industry trends.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
EDAP TMS is a medical equipment company. The healthcare sector is considered defensive. The chart will help you assess whether EDAP shares act as a defensive asset or, as a small company, are more volatile and follow overall market sentiment.
Market capitalization of the company, segment and market as a whole
EDAP - Market capitalization of the company EDAP TMS S.A.
EDAP TMS's market capitalization is a financial roadmap for non-invasive treatment in urology. The performance of this French company, a pioneer in high-intensity focused ultrasound (HIFU) for prostate cancer treatment, reflects the demand for gentle treatment methods. Its growth is a barometer of the adoption of its technology by doctors and patients worldwide.
EDAP - Share of the company's market capitalization EDAP TMS S.A. within the market segment - Therapeutic medical equipment
EDAP TMS's market share in therapeutic equipment reflects its leadership in high-intensity focused ultrasound (HIFU). Its market share is driven by the acceptance of this non-invasive technology for the treatment of prostate cancer and other conditions, making it a significant player in urology.
Market capitalization of the market segment - Therapeutic medical equipment
EDAP TMS is a global leader in high-intensity focused ultrasound (HIFU) for prostate cancer treatment. The chart below shows the overall market capitalization of the entire medical equipment sector. Its growth reflects the trend toward minimally invasive treatments in oncology.
Market capitalization of all companies included in a broad market index - GURU.Markets
EDAP TMS is a French company, a pioneer in ultrasound ablation for prostate cancer treatment. Its market capitalization is based on its unique non-invasive technology. The chart below shows the economic weight of high-tech medical equipment manufacturers.
Book value capitalization of the company, segment and market as a whole
EDAP - Book value capitalization of the company EDAP TMS S.A.
The book value of EDAP TMS, a manufacturer of urology equipment, is derived from its production facilities and R&D centers. The chart below shows the material basis of its medical business. Its growth reflects investments in the production and commercialization of its unique therapeutic systems.
EDAP - Share of the company's book capitalization EDAP TMS S.A. within the market segment - Therapeutic medical equipment
EDAP TMS is a company developing minimally invasive equipment for the treatment of urological diseases. Certified manufacturing facilities are required to produce these medical devices. The asset share chart shows how the company is investing in building its own physical infrastructure.
Market segment balance sheet capitalization - Therapeutic medical equipment
EDAP TMS is a pioneer in non-invasive ultrasound therapy. Its strength lies in its R&D centers and production lines, where this unique medical equipment is created. It's a capital-intensive technology business. The graph illustrates how dependent the entire medical technology industry is on owning its own manufacturing facilities.
Book value of all companies included in the broad market index - GURU.Markets
EDAP TMS's assets include manufacturing facilities and patents for high-intensity focused ultrasound (HIFU) equipment, a non-invasive prostate cancer treatment. The company's assets include technology offering an alternative to traditional surgery and radiation therapy.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - EDAP TMS S.A.
EDAP TMS is a pioneer in high-intensity focused ultrasound (HIFU) for prostate cancer treatment. Its balance sheet reflects its production capacity, but the market values its technology as a non-invasive alternative to surgery and radiation therapy. The chart shows how investors view the adoption of this technology by urologists worldwide.
Market to book capitalization ratio in a market segment - Therapeutic medical equipment
EDAP TMS is a company that produces medical equipment for the non-invasive treatment of urological diseases. It combines manufacturing capabilities with proprietary technologies. The chart shows how investors view its unique technology and its global market penetration.
Market to book capitalization ratio for the market as a whole
EDAP TMS is a company that develops and markets minimally invasive medical equipment for the treatment of urological diseases. The chart shows how the market values this high-tech medical solutions provider. The premium to its market capitalization reflects the value of its patented technologies and its position in the global market.
Debts of the company, segment and market as a whole
EDAP - Company debts EDAP TMS S.A.
EDAP TMS is a leader in therapeutic ultrasound, offering minimally invasive treatments. Its debt burden may reflect investments in R&D to expand the reach of its technology and in marketing to promote its systems in clinics worldwide, as illustrated by the financial strategy in this chart.
Market segment debts - Therapeutic medical equipment
EDAP TMS is a pioneer in the development of therapeutic ultrasound technologies for non-invasive treatments. This is an innovative field in medicine. This chart shows the financial standards for the medical device sector, where companies must raise capital to conduct clinical trials, obtain regulatory approvals, and bring their unique technologies to market.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio EDAP TMS S.A.
EDAP TMS is a French company, a pioneer in ultrasound therapy, particularly for prostate cancer treatment. Medical equipment requires constant investment in R&D and marketing. This chart shows the company's use of debt capital for its development, allowing us to assess its financial strategy and sustainability in the global market.
Market segment debt to market segment book capitalization - Therapeutic medical equipment
The development of minimally invasive urological equipment, like EDAP TMS, is a niche but stable market. This chart reflects the debt burden in the medical equipment sector. It allows us to assess how the financial strategy of this French company, a pioneer in its field, differs from that of large, diversified medical equipment manufacturers.
Debt to book value of all companies in the market
EDAP TMS is a pioneer in non-invasive ultrasound-based treatments. The development and promotion of new medical equipment requires significant investment. This chart allows us to assess whether their debt strategy for market capture and R&D funding is conservative or aggressive.
P/E of the company, segment and market as a whole
P/E - EDAP TMS S.A.
This chart for EDAP TMS S.A., a company that produces medical equipment for minimally invasive treatments, shows its market valuation. The metric reflects investor confidence in its high-intensity focused ultrasound (HIFU) technology and its potential to become a standard of care in urology and oncology.
P/E of the market segment - Therapeutic medical equipment
This chart shows the average market valuation for the therapeutic medical device industry, where EDAP TMS operates. This metric reflects how investors generally view the growth and innovation prospects in this industry. It helps understand whether the market values EDAP's technology above or below competitors' solutions.
P/E of the market as a whole
EDAP TMS is a medical technology company leading the field of non-invasive high-intensity focused ultrasound (HIFU) treatment for prostate cancer. The company's growth depends on the adoption of this technology by physicians and hospitals. This chart shows the current sentiment in the medical equipment sector. It helps understand how the market views HIFU's potential to become a standard of care and how this impacts EDAP's valuation.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company EDAP TMS S.A.
EDAP TMS develops and markets minimally invasive medical equipment for the treatment of urological conditions, specifically using high-intensity focused ultrasound (HIFU). Future growth depends on the adoption of its technology. This chart reflects market expectations regarding the adoption of HIFU as a standard treatment for prostate cancer and other conditions.
%20P%2FE%20EDAP%20TMS%20S.A.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-EDAP-TMS-S.A.&v=1772513520426 "Chart of the company's future (projected) P/E EDAP TMS S.A.")
Future (projected) P/E of the market segment - Therapeutic medical equipment
EDAP TMS is a French company and a global leader in therapeutic ultrasound. It produces equipment for the non-invasive treatment of prostate cancer and kidney stone dissolution. This chart shows expectations for the medical equipment sector, helping to understand how the market views this advanced and patient-friendly medical technology.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Therapeutic-medical-equipment&v=1772513520457 "Future (projected) P/E graph of the market segment - Therapeutic medical equipment")
Future (projected) P/E of the market as a whole
EDAP TMS is a pioneer in therapeutic ultrasound, offering minimally invasive treatments for prostate cancer and kidney stones. Their success depends on the acceptance of this technology by the medical community. This graph of overall expectations reflects the healthcare system's willingness to invest in innovation. Market optimism suggests that clinics will purchase new equipment to improve treatment outcomes.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772513520485 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit EDAP TMS S.A.
EDAP TMS is a leader in therapeutic ultrasound, offering minimally invasive treatments for prostate cancer and kidney stones. This chart reflects the adoption of its technologies in medical practice. Revenue growth is driven by increased sales of its equipment and the number of procedures performed using it, which generates recurring revenue.
Profit of companies in the market segment - Therapeutic medical equipment
Cyngn Inc. develops software for autonomous control of industrial vehicles such as forklifts. Profitability depends on the implementation of automation in warehouses and factories. This chart shows how the demand for increased efficiency and safety in logistics is creating a large market for industrial automation solutions.
Overall market profit
EDAP TMS is a global leader in therapeutic ultrasound. The company produces equipment for the non-invasive treatment of prostate cancer and kidney stone dissolution. The company's growth is driven by the implementation of its technologies in clinical practice, offering an alternative to traditional surgery and making the business less dependent on market cycles.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company EDAP TMS S.A.
EDAP TMS is a global leader in therapeutic ultrasound, offering minimally invasive devices for the treatment of prostate cancer and kidney stones. The company's revenue forecast depends on the adoption of its technologies in hospitals worldwide. This chart shows analyst expectations for the growth of the non-invasive surgery market and EDAP's position within it.
%20profit%20of%20the%20company%20EDAP%20TMS%20S.A.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-EDAP-TMS-S.A.&v=1772513520710 "Graph of future (projected) profit of the company EDAP TMS S.A.")
Future (predicted) profit of companies in the market segment - Therapeutic medical equipment
EDAP TMS is a global leader in therapeutic ultrasound. The company produces equipment for the non-invasive treatment of prostate cancer and kidney stone dissolution. This chart shows profitability forecasts for the medical device sector. It reflects the trend toward minimally invasive treatments that deliver better patient outcomes.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Therapeutic-medical-equipment&v=1772513520770 "Graph of future (predicted) profits of companies in a market segment - Therapeutic medical equipment")
Future (predicted) profit of the market as a whole
EDAP TMS S.A. is a pioneer in non-invasive ultrasound-based treatments, such as for prostate cancer. Demand for its equipment depends on the budgets of medical institutions. This graph of corporate profit projections provides insight into overall economic health, which influences hospitals' ability to invest in advanced medical technologies.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772513520848 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - EDAP TMS S.A.
EDAP TMS is a global leader in therapeutic ultrasound, offering minimally invasive devices for the treatment of prostate cancer and kidney stones. The company generates revenue from sales of equipment and consumables. The chart shows how investors value its technology, which offers an alternative to traditional surgery and radiation therapy.
P/S market segment - Therapeutic medical equipment
EDAP TMS S.A. is a French company and a global leader in therapeutic ultrasound. It develops and markets minimally invasive equipment for the treatment of prostate cancer and kidney stones. This chart shows the average market value for the sector, allowing one to assess how the market values EDAP's medical technologies and global presence.
P/S of the market as a whole
EDAP TMS is a global leader in therapeutic ultrasound. The company develops and markets equipment for the non-invasive treatment of urological conditions, including prostate cancer. This chart helps assess the market's willingness to value the company's revenue, offering innovative and gentle treatment methods, compared to the average.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company EDAP TMS S.A.
EDAP TMS is a global leader in therapeutic ultrasound, offering minimally invasive devices for the treatment of prostate cancer and kidney stones. This chart shows how investors estimate the company's future revenue. It reflects expectations for the growing adoption of its technology in hospitals worldwide as an alternative to traditional surgery.
%20P%2FS%20EDAP%20TMS%20S.A.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-EDAP-TMS-S.A.&v=1772513520980 "The graph of the company's future (projected) P/S EDAP TMS S.A.")
Future (projected) P/S of the market segment - Therapeutic medical equipment
EDAP TMS S.A. is a French company and a global leader in therapeutic ultrasound. It produces equipment for the non-invasive treatment of prostate cancer and kidney stone dissolution. The graph shows how the market estimates EDAP's future sales, reflecting the growing demand for minimally invasive medical technologies.
%20P%2FS%20market%20segment%20graph%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Therapeutic-medical-equipment&v=1772513521011 "Future (projected) P/S market segment graph - Therapeutic medical equipment")
Future (projected) P/S of the market as a whole
This graph reflects innovations in minimally invasive surgery. EDAP TMS is a leader in high-intensity focused ultrasound (HIFU) for prostate cancer treatment. The growing use of their technology in clinics worldwide demonstrates how non-invasive treatments are becoming increasingly popular, offering patients an effective alternative to traditional surgery.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772513521025 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales EDAP TMS S.A.
EDAP TMS is a global leader in therapeutic ultrasound. The company's revenue is generated through sales of its medical systems for the non-invasive treatment of prostate cancer and kidney stone fragmentation, as well as through the sale of consumables and services. This chart shows the growing adoption of its minimally invasive technologies in urology.
Sales of companies in the market segment - Therapeutic medical equipment
EDAP TMS is a global leader in therapeutic ultrasound. The company produces devices for the non-invasive treatment of prostate cancer and kidney stone dissolution. This chart shows total revenue in the therapeutic medical equipment sector. It reflects the trend toward minimally invasive procedures, which offer better results and patient comfort.
Overall market sales
EDAP TMS is a French company and a global leader in therapeutic ultrasound. It produces equipment for the non-invasive treatment of prostate cancer and kidney stone dissolution. Demand for its systems depends on hospital budgets. This general economic climate impacts the ability of medical institutions to invest in advanced therapeutic equipment.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company EDAP TMS S.A.
EDAP TMS is a global leader in therapeutic ultrasound. The company produces equipment for the non-invasive treatment of prostate cancer and kidney stone dissolution. The chart shows analyst revenue forecasts, reflecting their expectations for sales of this high-tech medical equipment to hospitals worldwide.
%20sales%20of%20the%20company%20EDAP%20TMS%20S.A.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-EDAP-TMS-S.A.&v=1772513521294 "Schedule of future (projected) sales of the company EDAP TMS S.A.")
Future (projected) sales of companies in the market segment - Therapeutic medical equipment
EDAP TMS is a global leader in therapeutic ultrasound, offering minimally invasive devices for the treatment of prostate cancer and kidney stones. The company's success depends on the adoption of its technologies in hospitals. This chart shows projected sales for the entire therapeutic medical equipment sector, reflecting general trends in urology and surgery.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Therapeutic-medical-equipment&v=1772513521350 "Schedule of future (projected) sales of companies in the market segment - Therapeutic medical equipment")
Future (projected) sales of the market as a whole
EDAP TMS is a pioneer in therapeutic ultrasound, offering minimally invasive treatments for prostate cancer and kidney stones. Demand for its equipment depends on hospital budgets and physician acceptance of the technology. This general economic activity impacts healthcare spending, which determines clinics' ability to purchase innovative equipment.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772513521457 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality EDAP TMS S.A.
EDAP TMS is a leader in therapeutic ultrasound, offering non-invasive treatments. This metric demonstrates the commercial success of its medical technologies. It shows what percentage of the company's equipment sales revenue turns into net profit, reflecting the demand for its innovative urology solutions.
Market segment marginality - Therapeutic medical equipment
EDAP TMS is a global leader in therapeutic ultrasound, offering minimally invasive treatments for urological conditions. Profitability depends on sales of its equipment and consumables. This chart shows the company's operating efficiency compared to other medical equipment manufacturers.
Market marginality as a whole
EDAP TMS is a global leader in therapeutic ultrasound, offering minimally invasive devices for the treatment of prostate cancer and kidney stones. Their growth depends on the adoption of their technologies in hospitals. This overall profitability curve impacts them through healthcare system budgets. In a stable economy, clinics are more willing to invest in new equipment.
Employees in the company, segment and market as a whole
Number of employees in the company EDAP TMS S.A.
EDAP TMS is a medical technology company, a leader in therapeutic ultrasound for urological treatments. This chart shows the size of its team. The growth in the number of engineers, sales, and clinical support specialists is directly related to the global adoption of its equipment in hospitals and clinics.
Share of the company's employees EDAP TMS S.A. within the market segment - Therapeutic medical equipment
EDAP TMS is a global leader in therapeutic ultrasound, particularly for the treatment of urological conditions. This chart shows the percentage of engineers and clinicians the company attracts in the high-intensity focused ultrasound (HIFU) niche. Its team is a pioneer in non-invasive surgery.
Number of employees in the market segment - Therapeutic medical equipment
EDAP TMS S.A. is a French company and a global leader in therapeutic ultrasound. This chart shows the overall employment in the therapeutic medical equipment sector. It illustrates the trend toward non-invasive treatments, where EDAP offers its technologies for the treatment of prostate cancer and the non-surgical dissolution of kidney stones.
Number of employees in the market as a whole
EDAP TMS is a global leader in therapeutic ultrasound, offering minimally invasive treatments for prostate cancer, for example. The company operates at the intersection of medicine and high technology. This graph illustrates the labor market, where the medical equipment sector is creating jobs for engineers, doctors, and sales professionals, introducing new treatment standards.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company EDAP TMS S.A. (EDAP)
EDAP TMS S.A. is a global leader in therapeutic ultrasound. This chart helps understand the business structure. The moderately high capitalization per employee reflects the combination of cutting-edge developments (high intellectual property value) and the need to manufacture and sell complex medical equipment worldwide, which requires a significant staff.
%20of%20the%20company%20EDAP%20TMS%20S.A.%20(EDAP)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-EDAP-TMS-S.A.-EDAP&v=1772513522085 "Chart of market capitalization per employee (in thousands of dollars) of the company EDAP TMS S.A. (EDAP)")
Market capitalization per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment
EDAP TMS is a leader in therapeutic ultrasound, offering minimally invasive solutions for the treatment of urological conditions. The company's value lies in its unique technology and patents. This chart shows the market premium they place on their medical innovations. Their high employee ratio reflects their strong position in their technological niche.
%20by%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Therapeutic-medical-equipment&v=1772513522107 "Market capitalization per employee (in thousands of dollars) by market segment - Therapeutic medical equipment")
Market capitalization per employee (in thousands of dollars) for the overall market
EDAP TMS S.A. is a French company that produces medical equipment for minimally invasive treatments, particularly using high-intensity focused ultrasound (HIFU). The company's employee rating reflects the value of its unique technology, patents, and installed base of equipment in clinics worldwide.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772513522220 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company EDAP TMS S.A. (EDAP)
EDAP TMS is a French medical technology company. They manufacture and sell equipment for minimally invasive treatments, including robotic-assisted ultrasound therapy (HIFU) for prostate cancer and lithotripsy (kidney stone fragmentation). This chart shows how effectively their R&D and sales teams generate net profit from sales of this expensive equipment.
%20Chart%20EDAP%20TMS%20S.A.%20(EDAP)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-EDAP-TMS-S.A.-EDAP&v=1772513522323 "Company Profit Per Employee (in thousands of dollars) Chart EDAP TMS S.A. (EDAP)")
Profit per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment
EDAP TMS produces medical equipment for the non-invasive treatment of urological conditions. This chart represents the industry benchmark. EDAP's performance depends on two factors: successful sales of their high-end systems and a growing revenue stream from consumables and service. This model allows for increased profitability per employee over time.
%20in%20the%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Therapeutic-medical-equipment&v=1772513522358 "Chart of profit per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment")
Profit per employee (in thousands of dollars) for the market as a whole
EDAP TMS (EDAP) is a medical equipment company primarily using high-intensity focused ultrasound (HIFU) for prostate cancer treatment. This metric reflects the profitability of their high-tech medical business, demonstrating how much revenue is generated by their team of engineers, manufacturers, and salespeople.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772513522389 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee EDAP TMS S.A. (EDAP)
This chart for EDAP TMS, a manufacturer of medical equipment for minimally invasive treatment of urological conditions, demonstrates the commercial success of its technologies. The growth in revenue per employee reflects the growing adoption of its ultrasound systems in hospitals worldwide.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-EDAP-TMS-S.A.-EDAP&v=1772513522430 "Sales chart per company employee EDAP TMS S.A. (EDAP)")
Sales per employee in the market segment - Therapeutic medical equipment
EDAP TMS is a medical technology company specializing in non-invasive treatments using high-intensity focused ultrasound (HIFU). This metric reflects the average revenue per employee in the segment. It allows us to assess how productive EDAP's team is in R&D and sales of its innovative equipment compared to other medical technology manufacturers.
Sales per employee for the market as a whole
EDAP TMS (EDAP) is a medical equipment company, specifically using high-intensity focused ultrasound (HIFU) technology for prostate cancer treatment. This metric reflects their commercial success. Growing revenue per employee indicates that their minimally invasive technology (Focal One devices) is finding increasing application in urology.
Short shares by company, segment and market as a whole
Shares shorted by company EDAP TMS S.A. (EDAP)
EDAP TMS S.A. is a French company that produces medical equipment, specifically high-intensity focused ultrasound (HIFU) for prostate cancer treatment. This chart reflects investor bets that its niche technology will face stiff competition from robotic surgery and other treatments.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-EDAP-TMS-S.A.-EDAP&v=1772513522628 "Short Shares Chart for the Company EDAP TMS S.A. (EDAP)")
Shares shorted by market segment - Therapeutic medical equipment
EDAP TMS (EDAP) is a French company specializing in therapeutic ultrasound, specifically HIFU (high-intensity focused ultrasound) technology for prostate cancer treatment. This chart shows the overall short position in the therapeutic medical equipment sector. It reflects market concerns about the speed of HIFU's adoption as a standard of care compared to surgery.
Shares shorted by the overall market
EDAP TMS (EDAP) produces medical equipment. Its business depends on hospital capital expenditures. When this indicator of overall pessimism rises, investors anticipate a recession. They fear that hospitals, faced with budget cuts, will immediately freeze purchases of new equipment.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator EDAP TMS S.A. (EDAP)
EDAP TMS is a French medical technology company, a pioneer in HIFU (high-intensity focused ultrasound) for minimally invasive prostate cancer treatment. This chart measures how investors perceive the speed of adoption of this technology. It shows when the stock is overbought on sales growth expectations or oversold on fears.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-EDAP-TMS-S.A.-EDAP&v=1772513522807 "RSI 14 indicator chart for the company's stock EDAP TMS S.A. (EDAP)")
RSI 14 Market Segment - Therapeutic medical equipment
EDAP TMS (EDAP) — "ultrasound" for *urology* (France). They are *pioneers* in *HIFU* (high-intensity ultrasound) for *non-invasive* treatment of *prostate* cancer and kidney stones. The "Therapeutic medical equipment" (medtech) sector thrives on R&D. RSI_14_Seg shows whether the *entire* sector is "overbought." This helps to differentiate: is EDAP's growth their "HIFU niche" or a general "overheating"?
RSI 14 for the overall market
EDAP TMS (EDAP), a medical equipment manufacturer, sees hospital budgets in this chart. During periods of euphoria and budget growth, clinics eagerly purchase innovative equipment. During moments of panic and cost cutting, these multi-million dollar purchases are postponed indefinitely.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast EDAP (EDAP TMS S.A.)
EDAP TMS is a French medical company and a pioneer in ultrasound therapy. It produces equipment for non-invasive prostate cancer treatment (HIFU - Focal One) and kidney stone fragmentation. This chart shows the average target price from analysts assessing the adoption rate of its HIFU technology in hospitals.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-EDAP-EDAP-TMS-S.A.&v=1772513522972 "A chart showing analyst consensus forecasts for the expected stock price. EDAP (EDAP TMS S.A.)")
The difference between the consensus estimate and the actual stock price EDAP (EDAP TMS S.A.)
EDAP - EDAP TMS is a French medical technology company, a pioneer in non-invasive focused ultrasound (HIFU) treatment, primarily for prostate cancer. This chart measures the gap between the current price and the consensus target price. It shows whether experts believe this robotic technology will be adopted by urologists worldwide.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-EDAP-EDAP-TMS-S.A.&v=1772513522996 "A chart showing the difference between the consensus forecast and the actual stock price. EDAP (EDAP TMS S.A.)")
Analyst consensus forecast for stock prices by market segment - Therapeutic medical equipment
EDAP TMS (EDAP) is a French medical device company, a pioneer in high-intensity focused ultrasound (HIFU) for non-invasive prostate cancer treatment. This chart shows general expectations for the therapeutic medical equipment sector. It reflects whether experts believe demand for "surgery without a scalpel" will grow.
Analysts' consensus forecast for the overall market share price
EDAP TMS S.A. is a French medical company, a leader in minimally invasive treatments. They produce equipment for lithotripsy (kidney stone crushing) and HIFU (ultrasound-assisted prostate ablation). This chart shows the overall market sentiment. For EDAP, whose business is selling expensive medical equipment, the overall optimism is important, as it reflects hospitals' willingness to invest in capital expenditures.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index EDAP TMS S.A.
EDAP TMS (EDAP) is a French medtech company, a pioneer in non-invasive treatments. Their signature technique is HIFU (high-intensity ultrasound), which they use to burn away prostate cancer and kidney stones without incisions. This graph is an adoption indicator. It measures their (very slow) progress in convincing doctors and hospitals to adopt their futuristic technology.
AKIMA Market Segment Index - Therapeutic medical equipment
EDAP TMS is a French company and a leader in ultrasound therapy. Its HIFU (Ablatherm) technology is used for minimally invasive prostate cancer treatment. This graph shows the average index for the therapeutic equipment sector. It allows one to assess how EDAP's innovative technology outperforms the industry average in terms of aggregate performance.
The AKIM Index for the overall market
EDAP TMS is a global leader in therapeutic ultrasound (HIFU). The company produces equipment for the non-invasive treatment of prostate cancer. This chart, reflecting the market average, provides context. It helps assess how this MedTech story, dependent on urologists' adoption of the technology, compares to overall macroeconomic trends.
